Maze Therapeutics, Inc. (MAZE) › Operating Cash FlowMaze Therapeutics, Inc. (MAZE) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2024: $75.95M2025: -$111.94M-$111.94M2024Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025-$111.94M-247.4%2024$75.95M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share